 | Up a level |
Hysek, C M; Simmler, L D; Ineichen, M; Grouzmann, E; Hoener, M C; Brenneisen, R; Huwyler, J; Liechti, M E (2011). The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans. Clinical pharmacology & therapeutics, 90(2), pp. 246-55. New York, N.Y.: Nature Publishing Group 10.1038/clpt.2011.78
